Kang, Tiejun
Zhang, Yi
Zhao, Jing
Li, Xiaoyan
Jiang, Heng
Niu, Xiaotong
Xie, Renqian
Ding, Xiaobin
Steele, Vaughn R.
Yuan, Ti-Fei
Funding for this research was provided by:
National Natural Science Foundation of China (31960181)
National Natural Science Foundation of China (82260364)
National Natural Science Foundation of China (81822017)
Science and Technology Program of Gansu Province (21ZD4FA032)
The Shanghai Municipal Education Commission—Gaofeng Clinical Medicine Grant Support (20181715)
National Institute on Drug Abuse (K12DA000167)
Article History
Accepted: 14 October 2022
First Online: 4 November 2022
Declarations
:
: Kang, Zhang, Zhao, Li, Heng Jiang, Niu, Xie, Ding, Steele, and Yuan declare no conflict of interest.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients being included in the study. Additional informed consent was obtained from all patients. Only basic demographic information about the patient appeared in the article.